The Blog
ChatGPT and medical communications – what are the implications?
Read In the wake of the 21st Century Cures Act (December 2016), the FDA has determined to accelerate the development of novel therapies and increase the speed of the review process, particularly in the field of cancer research.
Read More
Improving Diversity, Equity and Inclusion in Clinical Trials
Enhancing diversity, equity and inclusion (DEI) in clinical trial populations is a moral imperative. It has long been acknowledged that DEI is crucial for broadening the scope, creativity and innovativeness of medical research and bolsters success in solving complex problems whilst reducing inequities in health and disease.
Read More
InkLab Medical Communications
Effective continuing medical education (CME) programmes raise standards and enable HCPs to improve knowledge and skills through lifelong learning.
Read More
How to successfully measure success
The pressure mounts for publications and medical affairs teams to demonstrate the effectiveness of their activities, and so too does the temptation to stick with traditional metrics of success and the ones that make us look good. However, is that really effective?
Read More
Social media and the anti-vaccine movement
Vaccinations are estimated to save 2–3 million lives each year; however, with misinformation and ‘fake news’ so easily spread across social media platforms, the anti-vaccine movement has gathered momentum and threatens to undo substantial progress made against multiple preventable diseases.
Read More
The future of effective HCP communication
Compliant, obedient, and unknowledgeable. That’s how the patient landscape used to look to HCPs. Patients were wholly reliant on HCPs to provide them with the correct diagnosis and the most appropriate medication.
Read More
PR plan for pharma
The price of researching and developing new medicines is very high and so ensuring that a new drug is adopted is of paramount importance to pharma companies. Having a strategic Public Relations (PR) plan will help…
Read More
Why no-deal Brexit means fake pharma
Medicines are the most common medical intervention used across the UK and Europe. Unfortunately, falsified or fake medicines are entering global supply chains and have become a leading public health concern worldwide.
Read More
Brexit and the pharma industry
Brexit is only a stone’s throw away yet there are increasing concerns regarding the effect it will have on the pharmaceutical industry and the supply of medicines to patients.
Read More